Pregnancy and the COVID-19 Vaccine

As the COVID-19 vaccine becomes more readily available, a conversation between you and your clinical team may assist with decisions regarding the use of vaccines approved under EUA for the prevention of COVID-19 by pregnant patients. Important considerations include:

  • the level of activity of the virus in the community
  • the potential efficacy of the vaccine
  • the risk and potential severity of maternal disease, including the effects of disease on the fetus and newborn
  • the safety of the vaccine for the pregnant patient and the fetus.

For the most up-to-date information and resources visit The American College American College of Obstetricians and Gynecologists here.

Meet our Doctors & Nurse Practitioners

Dina M. Canavero,

MD, MPH, FACOG

Jacqueline Ho,

MD, FACOG

Blake R. Lambourne,

MD, FACOG

David H. Scates,

MD, FACOG

Denise L. Sweeney,

MD, FACOG

Richard J. Leach,

MD, FACOG

Analisa Marki-Dunn,

MD, FACOG

Catherine E. Taylor,

NP

Lia Walther,

NP

Jessica Beckmeyer,

NP

Maria Rivera,

NP

Allison Della Maggiora,

RN, MSN, FNP-C
MEET THE ENTIRE STAFF